deaths related to semaglutide reduces risk of all-cause death Semaglutide reduced mortality in obese

Regular IV therapy sessions, as recommended by healthcare providers, can help maintain optimal health and manage chronic conditions more effectively

Consult physicians if pregnant, nursing, or on diabetes meds, as GLP-1 modulation affects blood sugar

Smart Labs Now is not responsible for health or life outcomes based on the information or recommendations provided

FDA approves weight loss drug Zepbound to treat obstructive sleep apnea The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive sleep apnea

Hellstrom PM, et al

For those compounding the product, the FDA stated that it would not take action against 503A pharmacies until April 22, 2025, and would not take action against 503B outsourcing facilities until May 22, 2025